METHODS: Over a 4-year period, 65 patients (48 men, aged 61 ± 12 years) underwent total aortic arch replacement using the frozen elephant trunk technique for acute (n = 31) and chronic (n = 34) thoracic aortic dissections at our institution. We assessed diameter changes at 3 levels: the L1 segment at the stent graft level; the L2 segment at the thoraco-abdominal transition level and the L3 segment at the coeliac trunk level. True-lumen (TL) and false-lumen (FL) diameter changes were assessed at each level.
INTRODUCTION
The frozen elephant trunk (FET) technique has been increasingly employed over the last decade, and has contributed to continuous improvement for intended single-stage repair of complex acute and chronic thoracic aortic pathologies [1] [2] [3] . It has thereby also made secondary surgical and endovascular interventions feasible when necessary [4, 5] . Although the potential of thoracic endovascular aortic repair (TEVAR) alone in acute and chronic thoracic aortic pathologies has been extensively studied, there is little evidence on the potential of the FET technique in inducing remodelling of downstream aortic segments particularly concerning the various radial force capacities of standard TEVAR devices in comparison with FET devices [3, [6] [7] [8] .
The aim of this study was to evaluate early and mid-term clinical outcomes and to assess the potential of the FET technique to induce remodelling of downstream aortic segments in acute and chronic thoracic aortic dissections.
PATIENTS AND METHODS

Patients
Our study population consists of 65 patients (48 men, aged 61 ± 12 years) operated on between March 2013 and May 2017 who underwent a total aortic arch replacement using the FET technique. We used the short version (100 mm) of the Thoraflex TM hybrid graft (Vascutek, Inchinnan, UK) in all but 3 patients: 31 were treated for an acute aortic dissection (AAD), 34 underwent surgery for a chronic aortic dissection (CAD), including Stanford Type A †The first two authors equally contributed to this work. dissection and Stanford Type B dissection, non-A non-B dissection and remaining aortic dissection after previous Type A repair. Indications for the FET procedure depended on the entry tear location and the aortic diameter in acute and chronic settings. In AAD, the FET procedure was performed in patients with acute Type A and non-A non-B dissections as previously recommended, with an entry tear within the aortic arch or the proximal descending aorta [9] . In selected cases with an acute complicated Type B dissection without a suitable landing zone for primary TEVAR, the FET procedure was our treatment of choice as previously reported [10] . In CAD patients, the indication for FET depended on the diameter of the downstream aorta and the annual growth rate [11] and on the detection of new entry tears in the aortic arch that function as new primary entry tears leading to a rapid increase in diameter [12] . In Marfan patients, a diameter of 50 mm was set for elective surgical repair in CAD at our institution. In patients with connective tissue disease, our clinical perception refers to the point that primary usage of TEVAR technology is prohibited as long as the proximal landing zone is in native aortic tissue. Using the FET technique is justified, as the worst-case scenario here represents any extent of distal stent graft-induced new entry which is eligible for either distal TEVAR extension or classical thoraco-abdominal replacement. In any case, the primary intent of the strategy, being closure of the primary entry tear or of a large communication between lumina, can be effectively achieved. Reasons for early reintervention were either rapid diameter progression of the proximal descending aorta or ineffectiveness to seal the primary entry tear or multiple communications between lumina. TEVAR generally is our preferred method if suitable. However, we performed open repair in case of connective tissue disorders or in patients without a suitable distal landing zone. We evaluated early and mid-term outcomes.
Definition of clinical parameters
We defined the in-hospital mortality as death before discharge. Neurological injury was defined according to the Valve Academic Research Consortium and subclassified accordingly [13] . AAD was diagnosed when the onset of symptoms occurred less than 14 days before clinical presentation [14] .
Technique of FET implantation, perfusion management and neuroprotection
Our surgical technique has been described in detail [1, 10, 15] . Patients undergoing the FET procedure were monitored with bilateral radial and left-sided femoral blood pressure measurements and near-infrared spectroscopy routinely. Perfusion flow was adjusted to pressure and flow and according to near-infrared spectroscopy values. We did not administer cerebrospinal fluid drainage.
The right subclavian artery was cannulated for arterial return in all patients directly or via an 8-mm Dacron prosthesis according to the treating physician's preference. Target core body temperature for lower body hypothermic circulatory arrest was [25] [26] C. Selective antegrade cerebral perfusion was used in all patients, and the perfusate temperature equalled the core temperature in patients operated on under hypothermic circulatory arrest. Antegrade cold blood cardioplegia and retrograde cold blood cardioplegia were used for myocardial protection [16] . The beating heart technique was used selectively in patients who presented with no root involvement, had an ascending prosthesis already in place or whose root had been repaired or replaced during cooling before lower body hypothermic arrest. We used a modified Hannover protocol [2] using 300 ml of antegrade normothermic blood perfusion. We never clamped the ascending aorta in acute scenarios due to the unpredictable behaviour of the acutely dissected ascending aorta.
Data collection and follow-up protocol
Data were collected retrospectively from our clinical database. Computed tomography scans were performed preoperatively, before discharge, after 6 and 12 months and annually thereafter in our outpatient clinic. To evaluate diameter changes, the aorta was categorized into 3 segments: the L1 segment at the stent level; the L2 segment at the thoraco-abdominal transition level and the L3 segment at the coeliac trunk level. Measurements of total aortic true-lumen (TL) diameters were taken at the largest part of each segment using multiplanar reconstruction, always in the plane perpendicular to the manually corrected local aortic centre line. Total aortic diameter was calculated as the mean of the maximum aortic diameter and minimal aortic diameter. The false-lumen (FL) diameter was calculated as the difference between the total aortic diameter and TL diameter.
Statistical analysis
All values are expressed as n (%) or mean ± standard deviation. IBM SPSS Statistics 24 for Macintosh (Armonk, NY, USA) was used for statistical analysis. Categorical variables were compared using the v 2 test with the calculation of exact P-values. In case of small group sizes (n < _ 5), the Fisher's exact test was used. The MannWhitney U-test served to compare continuous variables. For analysis of survival and freedom from aortic reinterventions, the Kaplan-Meier estimates were used. The log-rank test was used to detect statistical differences in the Kaplan-Meier survival estimates. Mean diameters were compared with preoperative diameters via the paired t-test by calculating exact 2-sided P-values in each group. P-values were considered significant when P-value <0.05.
RESULTS
Chronic health conditions, risk factors and previous aortic procedures
Patient demographics are summarized in Table 1 . Forty-eight men and 17 women who were aged 61 ± 12 years underwent total arch replacement using the FET technique. Arterial hypertension was common in both groups (86 vs 91%). Marfan syndrome was diagnosed clinically based on the Ghent criteria/ according to genetic testing in 3 AAD and 5 CAD patients. Twenty-eight (82%) CAD patients had already undergone previous aortic or cardiac surgery; however, this was less often the case in patients with AAD (n = 7, 24%) (P < 0.001).
Intraoperative data and concomitant procedures
The most frequent concomitant procedure was aortic root replacement using a (biological) valved conduit (CAD n = 4; AAD n = 5). Carotid-subclavian bypass was performed in 5 CAD patients before the FET procedure. Concomitant cardiac and vascular procedures and additional intraoperative data are summarized in Table 2 .
Outcome characteristics and follow-up Figure 1 shows representative computed tomographic angiography scans before and after implantation of the FET prosthesis. There were no intraoperative deaths. In-hospital mortality was 6%. Reasons for mortality were multiorgan failure in both CAD patients and major stroke in both patients with AAD. The disabling stroke rate was 6% in CAD and 13% in AAD patients. We observed no symptomatic spinal cord injury in this series. Sixtyone patients were discharged from hospital. Outcome characteristics are summarized in Table 3 . Follow-up period was 12 ± 12 months. Eleven patients required secondary interventions after repair for CAD and 7 after repair for AAD. In CAD patients, 6 patients underwent TEVAR and 5 classic TA replacement. Six AAD patients received TEVAR. Figure 2 shows the Kaplan-Meier estimates for survival in CAD and AAD patients. Figure 3 shows the Kaplan-Meier estimates for freedom from aortic reinterventions in both groups.
Aortic characteristics
Post-procedural computed tomographic angiography scans were available in 27 AAD and 31 CAD patients. Eleven AAD and 19 CAD patients completed follow-up after 6 months. Computed tomographic angiography examinations were carried out after 12 months (8 AAD and 15 CAD patients), after 24 months (5 AAD and 6 CAD patients) and after 36 months (2 AAD and 6 CAD patients). Mean total aortic, TL and FL diameters are shown for the respective segment (L1-L3) and are depicted according to either AAD or CAD in Tables 4 and 5, respectively. L1-segment at the stent level. The total aortic diameter remained stable in CAD patients (56 ± 10 mm vs 54 ± 14 mm after 36 months P = 0.27), whereas the TL diameter increased significantly (15 ± 7 mm vs 28 ± 2 mm after 24 months, P = 0.001) and the FL diameter decreased significantly postoperatively and during later follow-up when compared with preoperative imaging (40 ± 11 mm vs 24 ± 13 mm after 36 months, P = 0.003). In contrast, total aortic diameters in AAD patients decreased postoperatively and the difference reached statistical significance after 12 months when compared with preoperative imaging (44 ± 10 mm vs 42 ± 9 mm, P = 0.024), but there was no statistical difference in TL diameter changes postoperatively. However, FL diameters decreased and the difference reached statistical significance after 24 months when compared with preoperative diameters (23 ± 11 mm vs 8 ± 3 mm, P = 0.019).
L2-segment at the thoraco-abdominal transition. The total aortic diameter increased significantly at the L2 level in CAD patients (44 ± 9 mm vs 50 ± 9 mm after 12 months P = 0.023). The TL diameter increased significantly (15 ± 8 mm vs 28 ± 2 mm after 36 months P = 0.008) and the FL diameter decreased significantly during later follow-up when compared with preoperative imaging (29 ± 11 mm vs 24 ± 7 mm after 24 months, P = 0.001). In AAD patients, the total aortic diameter increased significantly (38 ± 10 mm vs 41 ± 10 mm postoperatively, P = 0.002). The mean Data are presented as mean ± standard deviation or as n (%). AAD: acute aortic dissection; CAD: chronic aortic dissection. TL diameter increased significantly (17 ± 13 mm vs 23 ± 8 mm postoperatively, P = 0.01) whereas there was no statistical difference in FL diameter changes postoperatively.
L3-segment at the coeliac trunk. The total aortic diameter at the L3 level increased significantly in CAD patients (36 ± 8 mm vs 43 ± 8 mm after 24 months, P = 0.033). The TL diameter increased significantly after 6 months (14 ± 8 mm vs 15 ± 5 mm after, P = 0.035), whereas there was no statistical difference in FL diameter changes during later follow-up when compared with preoperative imaging. In AAD patients, the total aortic diameter increased significantly (32 ± 9 mm vs 33 ± 4 mm after 6 months, P = 0.042). The mean TL diameter increased significantly after 6 months (17 ± 11 mm vs 21 ± 10 mm, P = 0.023), whereas the FL diameter decreased significantly (15 ± 12 mm vs 11 ± 9 mm postoperatively, P = 0.001).
DISCUSSION
The FET technique is associated with an excellent clinical outcome in a complex cohort of patients, and also effectively induces remodelling in downstream aortic segments in acute and chronic thoracic aortic dissections. The need for secondary interventions in downstream segments, which mainly depends on the extent of the underlying disease process, remains substantial. Further studies are required to assess long-term outcome of this approach. Our cohort's chronic health conditions and risk factors resemble those described in studies addressing related aortic dissection issues [3, 6, 7] . Six patients sustained an AAD Type B as an unrelated new event after primary replacement of the ascending aorta-a frequent anomaly, particularly in patients with connective tissue disorders [17] .
In-hospital mortality was 6% with no differences between the 2 groups, which was comparable with other series [3, 5, 18, 19] . Although there are fewer reservations about treating postdissection aneurysmal formation after AAD via the FET technique, optimal decision-making algorithms in the acute setting still Total aortic diameter (mm) L1 44 ± 10 47 ± 9 (P = 0.09) 44 ± 9 (P = 0.20) 42 ± 9 (P = 0.024) 34 ± 5 (P = 0.27) 31 ± 2 (P = 0.34) L2 38 ± 10 41 ± 10 (P = 0.002) 46 ± 9 (P = 0.24) 43 ± 11 (P = 0.44) 37 ± 6 (P = 0.65) 34 ± 4 (P = 0.37) L3 32 ± 9 32 ± 8 (P = 1) 33 ± 4 (P = 0.042) 32 ± 5 (P = 0.060) 30 ± 2 (P = 0.37) 28 ± 1 (P = -) True-lumen diameter (mm) L1 23 ± 12 26 ± 5 (P = 0.25) 28 ± 6 (P = 0.88) 28 ± 4 (P = 0.83) 27 ± 2 (P = 0.058) 27 ± 0 (P = 0.56) L2 17 ± 13 23 ± 8 (P = 0.010) 26 ± 11 (P = 0.22) 25 ± 7 (P = 0.60) 24 ± 10 (P = 0.097) 22 ± 8 (P = 0.21) L3 17 ± 11 21 ± 9 (P < 0.001) 21 ± 10 (P = 0.023) 20 ± 8 (P = 0.75) 18 ± 9 (P = 0.049) 17 ± 12 (P = 0.80) False-lumen diameter (mm) L1 23 ± 11 22 ± 8 (P = 0.38) 16 ± 10 (P = 0.14) 14 ± 8 (P = 0.16) 8 ± 3 (P =0.019) 4 ± 2 (P = 0.53) L2 20 ± 11 18 ± 9 (P = 0.17) 20 ± 11 (P = 0.61) 18 ± 12 (P = 0.97) 13 ± 7 (P = 0.22) 12 ± 12 (P = 0.50) L3 15 ± 12 11 ± 9 (P = 0.001) 11 ± 11 (P = 0.35) 11 ± 9 (P = 0.69) 12 ± 10 (P = 0.11) 11 ± 11 (P = 0.50) Data are presented as mean ± standard deviation. Mean aortic diameter measurements of aortic, true-lumen and false-lumen diameters were taken at each segment and compared with preoperative values. L1: segment at the stent level; L2: segment at the thoraco-abdominal transition and L3: segment at the coeliac trunk. remain under debate. A narrow TL resulting in malperfusion is associated with higher mortality in conjunction with AAD [20] . The FET technique addresses the problem of TL collapse resulting in malperfusion of the lower body including renal and visceral malperfusion or in the presence of several communications between the 2 lumina in the distal aortic arch or proximal descending aorta. The careful selection of patients should lead to favourable perioperative outcomes for Type A AAD patients, while patient survival remains the primary aim. Fortunately, none of our patients experienced a symptomatic spinal cord injury. Except for the 3 patients operated on when we first began employing the FET technique on a regular basis, we now routinely use the 100-mm version of the stent graft and perform metachronous secondary distal extension if needed, being aware that the length of the stented part is just one contributing factor [21] . Nevertheless, the number of simultaneously occluded thoracic segmental arteries is one component in the occurrence of symptomatic spinal cord injury [22] . Therefore, secondary distal extension should be performed after adapting spinal cord perfusion to the modified conditions [23] . The aim of the FET procedure is to close distally-located primary entry tears, thereby inducing FL thrombosis, resulting in depressurization and, ideally, shrinkage [24] . In many clinical Type A aortic dissection scenarios, where the location of the primary entry tear is more proximal in the ascending aorta, ascending and hemiarch replacement is sufficient to close the primary entry tear and induce stability. However, secondary entry tears may develop at the level of the arch anastomosis and thereby function as new primary entry tears leading to a rapid increase in diameter. Furthermore, the number of communications between the lumina and perfusion of the FL affects aortic growth [12] . The FET technique addresses this anomaly by closing these communications at several levels, initiating FL thrombosis and reducing the wall shear stress at one of its most vulnerable areas, namely the convexity of the aortic arch and proximal descending aorta [25] . This extensive strategy has the potential to enable a thorough single-step procedure that potentially lowers the number of secondary aortic-related interventions in downstream segments. Nevertheless, the complexity of this procedure must be weighed against the higher risk associated with it. Interestingly, the remodelling was equally effective in acute and chronic conditions, supporting this concept also in scenarios where several years have passed between the initial event and the need for a FET procedure. Our findings are generally similar to the results other studies concerning aortic remodelling of the downstream aorta [6, 7] .
Distal aortic reinterventions were frequently required, often the case after classical TEVAR in acute and chronic pathologies [8] . It is our strategy to perform the FET operation and evaluate the need for any kind of immediate secondary aortic intervention (TEVAR) after the patient's first completed computed tomography scan. We evaluate whether the entire pathology has been adequately resolved or if a watch-and-wait strategy is advisable for patients whose need for secondary aortic interventions cannot be immediately determined. In any case, it is our preferred strategy to defer any kind of secondary procedure to enable the spinal cord's blood supply to collateralize, thus minimizing the residual risk for symptomatic spinal cord injury. This strategy translates into excellent outcomes following secondary TEVAR procedures, evident in the avoidance of symptomatic spinal cord injury and late remodelling. Classical surgical extension is also possible from the distal end of the prosthesis' stent graft component. However, the risk of fabric porosity resulting in intraoperative bleeding proximal to the clamped stent graft portion of the FET prosthesis remains. In any case, the stent graft portion serves as a very stable platform for both TEVAR and classical surgical extension.
Limitations and strength
The follow-up period of this series is brief, and we may not have fully explored the entire remodelling potential. However, our series comprises a variety of underlying acute and chronic dissective aortic pathologies (Types A, B and non-A non-B) and reveals a gain in knowledge about several different conditions.
CONCLUSION
The FET technique is not only associated with excellent clinical outcomes in complex patient cohorts, but also effectively induces Postoperatively (n = 31) 6 months (n = 19) 12 months (n = 15) 24 months (n = 6) 36 months (n = 6)
Total aortic diameter (mm) L1 56 ± 10 57 ± 8 (P = 0.69) 53 ± 11 (P = 0.12) 57 ± 14 (P = 0.26) 62 ± 13 (P = 0.37) 54 ± 14 (P = 0.27) L2 44 ± 9 44 ± 9 (P = 0.59) 45 ± 8 (P = 0.16) 50 ± 9 (P = 0.02) 51 ± 7 (P = 0.11) 42 ± 10 (P = 0.43) L3 36 ± 8 36 ± 7 (P = 0.96) 36 ± 7 (P = 0.015) 39 ± 8 (P = 0.008) 43 ± 8 (0.033) 32 ± 5 (P = 0.077) True-lumen diameter (mm) L1 15 ± 7 20 ± 6 (P < 0.001) 24 ± 6 (P < 0.001) 25 ± 5 (P = 0.002) 28 ± 2 (P = 0.001) 29 ± 2 (P = 0.063) L2 15 ± 8 17 ± 8 (P = 0.007) 18 ± 9 (P = 0.003) 22 ± 8 (P = 0.001) 27 ± 3 (P = 0.001) 28 ± 2 (P = 0.008) L3 14 ± 8 14 ± 5 (P = 0.76) 15 ± 5 (P = 0.035) 17 ± 7 (P = 0.069) 15 ± 6 (P = 0.27) 18 ± 8 (P = 0.47) False-lumen diameter (mm) L1 40 ± 11 37 ± 12 (P = 0.001) 29 ± 13 (P < 0.001) 32 ± 17 (P = 0.004) 32 ± 16 (P = 0.026) 24 ± 13 (P = 0.003) L2 29 ± 11 27 ± 11 (P = 0.011) 26 ± 12 (P = 0.03) 28 ± 13 (P = 0.062) 24 ± 7 (P = 0.001) 14 ± 11 (P = 0.059) L3 21 ± 9 22 ± 10 (P = 0.62) 22 ± 9 (P = 0.89) 22 ± 9 (P = 0.53) 27 ± 3 (P = 0.79) 15 ± 11 (P = 0.24)
Data are presented as mean ± standard deviation. Mean aortic diameter measurements of aortic, true-lumen and false-lumen diameters were taken at each segment and compared with preoperative values. L1: segment at the stent level; L2: segment at the thoraco-abdominal transition and L3: segment at the coeliac trunk.
remodelling in downstream aortic segments in acute and chronic thoracic aortic dissections. Depending mainly on the extent of the underlying disease process, the need for secondary interventions in downstream segments remains substantial. Further investigation is warranted to assess the long-term outcomes of the FET approach.
